Polar Asset Management Partners Inc. Astria Therapeutics, Inc. Transaction History

Polar Asset Management Partners Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.83 - $13.51 $70,640 - $108,080	8,000 Added 16.56%	56,300 $512,000
Q1 2024 May 15, 2024	BUY	$6.99 - $16.69 $337,617 - $806,127	48,300 New	48,300 $679,000
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $843,360 - $1.19 Million	75,300 Added 95.44%	154,200 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$7.44 - $14.89 $587,016 - $1.17 Million	78,900 New	78,900 $1.17 Million

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $135M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.